{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:41:55Z","timestamp":1791909715703,"version":"4.3.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81400981"],"award-info":[{"award-number":["81400981"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019349","name":"Nanjing Medical Science and Technique Development Foundation","doi-asserted-by":"publisher","award":["QRX17179"],"award-info":[{"award-number":["QRX17179"]}],"id":[{"id":"10.13039\/501100019349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.seizure.2021.09.007","type":"journal-article","created":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T02:12:26Z","timestamp":1631585546000},"page":"189-194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Predictors and prognoses of epilepsy after anti-neuronal antibody-positive autoimmune encephalitis"],"prefix":"10.1016","volume":"92","author":[{"given":"Shan-shan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-fang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-ping","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-jian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2021.09.007_bib0001","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1708712","article-title":"Antibody-mediated encephalitis","volume":"378","author":"Dalmau","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.seizure.2021.09.007_bib0002","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1055\/s-0036-1585453","article-title":"Autoantibody-associated central nervous system neurologic disorders","volume":"36","author":"Linnoila","year":"2016","journal-title":"Semin Neurol"},{"key":"10.1016\/j.seizure.2021.09.007_bib0003","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/WCO.0000000000000449","article-title":"Seizures and risk of epilepsy in autoimmune and other inflammatory encephalitis","volume":"30","author":"Spatola","year":"2017","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.seizure.2021.09.007_bib0004","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/epi.12127","article-title":"Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy","volume":"54","author":"Brenner","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.09.007_bib0005","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.seizure.2019.12.002","article-title":"New-onset refractory status epilepticus: a retrospective cohort study","volume":"74","author":"Gugger","year":"2020","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2021.09.007_bib0006","doi-asserted-by":"crossref","first-page":"577","DOI":"10.4103\/0972-2327.120476","article-title":"Autoimmune encephalitis: a potentially reversible cause of status epilepticus, epilepsy, and cognitive decline","volume":"16","author":"Pandit","year":"2013","journal-title":"Ann Indian Acad Neurol"},{"key":"10.1016\/j.seizure.2021.09.007_bib0007","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1212\/WNL.0000000000001940","article-title":"Critical Care EEG Monitoring Research Consortium (CCEMRC). New-onset refractory status epilepticus: etiology, clinical features, and outcome","volume":"85","author":"Gaspard","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2021.09.007_bib0008","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/jamaneurol.2016.5429","article-title":"Neurological autoantibody prevalence in epilepsy of unknown etiology","volume":"74","author":"Dubey","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.seizure.2021.09.007_bib0009","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s11845-018-1777-2","article-title":"Neurological autoantibodies in drug-resistant epilepsy of unknown cause","volume":"187","author":"Tecellioglu","year":"2018","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.seizure.2021.09.007_bib0010","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.eplepsyres.2016.12.010","article-title":"Epilepsy surgery in drug resistant temporal lobe epilepsy associated with neuronal antibodies","volume":"129","author":"Carre\u00f1o","year":"2017","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2021.09.007_bib0011","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: position paper of the ILAE commission for classification and terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.09.007_bib0012","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s13311-019-00750-3","article-title":"Autoimmune epilepsy","volume":"16","author":"Husari","year":"2019","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.seizure.2021.09.007_bib0013","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis[J]","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.seizure.2021.09.007_bib0014","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: a practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.09.007_bib0015","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1212\/WNL.0000000000003173","article-title":"Anti-LGI1 encephalitis: clinical syndrome and long-term follow-up","volume":"87","author":"van Sonderen","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2021.09.007_bib0016","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.seizure.2021.09.007_bib0017","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jocn.2019.07.049","article-title":"Clinical features and long-term outcomes of seizures associated with autoimmune encephalitis: a follow-up study in East China","volume":"68","author":"Yao","year":"2019","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.seizure.2021.09.007_bib0018","doi-asserted-by":"crossref","first-page":"e2185","DOI":"10.1212\/WNL.0000000000007475","article-title":"Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABABR encephalitis","volume":"92","author":"de Bruijn","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2021.09.007_bib0019","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.seizure.2018.06.021","article-title":"Electroclinical features of seizures associated with autoimmune encephalitis","volume":"60","author":"Steriade","year":"2018","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2021.09.007_bib0020","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jneuroim.2017.08.010","article-title":"Neurobehavioral outcomes in autoimmune encephalitis","volume":"312","author":"Yeshokumar","year":"2017","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.seizure.2021.09.007_bib0021","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jns.2018.10.026","article-title":"Factors underlying the development of chronic temporal lobe epilepsy in autoimmune encephalitis","volume":"396","author":"Casciato","year":"2019","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.seizure.2021.09.007_bib0022","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.yebeh.2018.10.038","article-title":"Seizure characteristics, treatment, and outcome in autoimmune synaptic encephalitis: a long-term study","volume":"94","author":"Zhang","year":"2019","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2021.09.007_bib0023","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.seizure.2019.04.022","article-title":"Long-term epilepsy after early post-stroke status epilepticus","volume":"69","author":"Abraira","year":"2019","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2021.09.007_bib0024","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jocn.2015.06.032","article-title":"Causes and outcomes of new onset status epilepticus and predictors of refractoriness to therapy","volume":"26","author":"Jayalakshmi","year":"2016","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.seizure.2021.09.007_bib0025","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3389\/fncel.2018.00386","article-title":"Neurologic alterations due to respiratory virus infections","volume":"12","author":"Bohmwald","year":"2018","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.seizure.2021.09.007_bib0026","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1001\/archneurol.2011.2985","article-title":"Autoimmune epilepsy: clinical characteristics and response to immunotherapy","volume":"69","author":"Quek","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.seizure.2021.09.007_bib0027","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/annonc\/mdz083","article-title":"Neuronal autoantibodies associated with cognitive impairment in melanoma patients","volume":"30","author":"Bartels","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.seizure.2021.09.007_bib0028","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.seizure.2018.05.004","article-title":"Efficacy of antiepileptic drugs in autoimmune epilepsy: a systematic review","volume":"59","author":"Cabezudo-Garc\u00eda","year":"2018","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2021.09.007_bib0029","doi-asserted-by":"crossref","first-page":"e353","DOI":"10.1212\/NXI.0000000000000353","article-title":"Antiepileptic drug therapy in patients with autoimmune epilepsy","volume":"4","author":"Feyissa","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.seizure.2021.09.007_bib0030","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3389\/fneur.2018.00579","article-title":"Clinical management of epilepsy with glutamic acid decarboxylase antibody positivity: the interplay between immunotherapy and anti-epileptic drugs","volume":"9","author":"M\u00e4kel\u00e4","year":"2018","journal-title":"Front Neurol"},{"key":"10.1016\/j.seizure.2021.09.007_bib0031","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/epi.14490","article-title":"Increased adverse events associated with antiepileptic drugs in anti-leucine-rich glioma-inactivated protein 1 encephalitis","volume":"59","author":"Shin","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.09.007_bib0032","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.3389\/fneur.2018.01136","article-title":"Characteristics of seizure and antiepileptic drug utilization in outpatients with autoimmune encephalitis","volume":"9","author":"Huang","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.seizure.2021.09.007_bib0033","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jaut.2018.10.014","article-title":"Prognosticating autoimmune encephalitis: a systematic review","volume":"96","author":"Broadley","year":"2019","journal-title":"J Autoimmun"},{"key":"10.1016\/j.seizure.2021.09.007_bib0034","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/epi.16571","article-title":"Acute symptomatic seizures secondary to autoimmune encephalitis and autoimmune-associated epilepsy: conceptual definitions","volume":"61","author":"Steriade","year":"2020","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.09.007_bib0035","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/acn3.520","article-title":"Seizure semiology: an important clinical clue to the diagnosis of autoimmune epilepsy","volume":"5","author":"Lv","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.seizure.2021.09.007_bib0036","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1172\/JCI125178","article-title":"Autoimmune seizures and epilepsy","volume":"129","author":"Geis","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.seizure.2021.09.007_bib0037","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1111\/epi.16282","article-title":"Seizure specificities in patients with antibody-mediated autoimmune encephalitis","volume":"60","author":"Vogrig","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.09.007_bib0038","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.yebeh.2016.04.046","article-title":"Paraneoplastic epilepsy","volume":"61","author":"Serafini","year":"2016","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2021.09.007_bib0039","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ana.24858","article-title":"Anti-LGI1 encephalitis is strongly associated with HLA-DR7 and HLA-DRB4","volume":"81","author":"van Sonderen","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/j.seizure.2021.09.007_bib0040","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/epi.12879","article-title":"Postencephalitic epilepsy: clinical characteristics and predictors","volume":"56","author":"Singh","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.09.007_bib0041","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3389\/fninf.2018.00086","article-title":"Analytic Tools for post-traumatic epileptogenesis biomarker search in multimodal dataset of an animal model and human patients","volume":"12","author":"Duncan","year":"2018","journal-title":"Front Neuroinform"},{"key":"10.1016\/j.seizure.2021.09.007_bib0042","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S1474-4422(17)30460-X","article-title":"The SeLECT score is inappropriate to predict post-stroke epilepsy","volume":"17","author":"Finsterer","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.seizure.2021.09.007_bib0043","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1136\/jnnp-2020-325275","article-title":"Clinical spectrum of high-titre GAD65 antibodies","volume":"92","author":"Budhram","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.seizure.2021.09.007_bib0044","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.yebeh.2018.01.021","article-title":"Antiglutamic acid decarboxylase 65 (GAD65) antibody-associated epilepsy","volume":"80","author":"Daif","year":"2018","journal-title":"Epilepsy Behav"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131121003058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131121003058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T02:00:34Z","timestamp":1761012034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131121003058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":44,"alternative-id":["S1059131121003058"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2021.09.007","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors and prognoses of epilepsy after anti-neuronal antibody-positive autoimmune encephalitis","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2021.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}